The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

21 Jun 2011 07:00

RNS Number : 7775I
JZ Capital Partners Ltd
21 June 2011
 



JZ CAPITAL PARTNERS LIMITED

(Registration No. 48761)

 

Registered Office:

2ND FLOOR, REGENCY COURT, GLATEGNY ESPLANADE, ST. PETER PORT,

GUERNSEY, GY1 3NQ

___________________________

 

TELEPHONE: + 44 1481 720321

FACSIMILE: + 44 1481 716117

E-MAIL: JZCP@bfgl.com

 

Interim Management Statement - Q1 2011

21 June 2011

 

JZ Capital Partners Limited ("JZCP"), the London listed closed ended investment company which principally invests in US and European micro cap buyouts, today announces its Interim Management Statement ("IMS") for the period from 1 March 2011 to 31 May 2011.

 

Highlights

 

·; Further narrowing of the Net Asset Value ("NAV") discount to 23%

·; NAV per share increase of 6% from $8.93 to $9.03 (on an annualised basis)

·; Dividend of 7.5 cents and a special dividend of 2.0 cents

·; European investments increased by $31.5 million over the first quarter, following the investments in two Spanish companies, Docout and Ombuds

·; First $7.7 million acquisition in water treatment "vertical" of Nashville Chemical, a manufacturer of industrial water systems products

·; Additional $1.0 million investment made in Milestone Aviation, a helicopter leasing business

·; 22.8% of the position in TAL International Group was sold in a secondary share offering, creating a gain of $10.8 million

·; At the end of the period, the portfolio consisted of 42 companies across eight industries

·; JZCP is well positioned to take advantage of the strong pipeline of investment opportunities as the private equity outlook continues to improve

 

David Zalaznick, Founder and Investment Advisor of JZCP said:

 

"I am delighted that the underlying investments in the portfolio continue to perform well. Our ongoing commitment to provide shareholders with a diversified pool of assets through our value-orientated investment strategy has resulted in the successful completion of two new investments in Spain."

 

Net Asset Value Growth

In the three months to 31 May 2011, JZCP's net assets increased at an annualized rate of 6%, from $8.93 to $9.06 per share. Our share price also increased from £4.12 to £4.24 ($6.64 to $6.96), further narrowing the NAV discount to 23%. JZCP continues to report positive news for its shareholders.

 

The source of the NAV growth is as follows:

 

Net Asset Value per Ordinary Share as of 28 February 2011

$8.93

+ Increase in Underlying Investments ($ per Share Impact)

0.06

+ Income from Investments ($ per Share Impact)

0.18

- ZDP Dividend Accrual ($ per Share Impact)

(0.02)

- Foreign Exchange Effects ($ per Share Impact)

(0.01)

- Fees and Expenses ($ per Share Impact)

(0.08)

Net Asset Value per Ordinary Share as of 31 May 2011

$9.06

 

The primary driver of the $0.06 increase in underlying investments is due to the strong operating performance and subsequent increase in value of three private investments: Galson Laboratories (our Testing Services company), Dantom Systems, and Dekko Technologies. This was offset by a $0.08 decrease in the values of our three listed equities - TAL International Group, Safety Insurance and UTI - which was due to the challenging environment facing US stock markets at the end of May.

 

For the three months ended 31 May 2011, JZCP's NAV increased by $8.5 million, as summarized below:

 

 28/2/2011

 31/5/2011

Net Asset Value ($000's) (1)

$580,788

$589,264

Number of Ordinary Shares Outstanding (000's)

65,019

65,019

Net Asset Value per Ordinary Share ($)

$8.93

$9.06

Market Price per Share ($)

$6.64

$6.96

NAV to Market Price Discount

26%

23%

 

(1) Per JZCP Board.

 

 

Recent Events (1 March 2011 - 31 May 2011)

·; On 4 March 2011, our water treatment "vertical" made its first acquisition, a $7.7 million investment in Nashville Chemical which provides products for industrial water systems. Our $7.7 million investment consists of $3.85 million of notes, $3.85 million of preferred stock and $40,000 of common stock. JZCP holds a 50.0% ownership stake in both the notes and preferred stock securities and a 40% ownership stake in the common stock security.

 

·; JZCP's interest in European investments increased by $31.5 million over the first quarter following the acquisitions of Docout and Ombuds. The European business also made three direct loans to these companies.

 

·; We also made additional investments totaling $1.0 million in Milestone Aviation, a helicopter leasing business, bringing our current exposure to $4.4 million, or 43.7% of our $10 million commitment.

·; We purchased £5m of UK gilts in May as the first step in earning a return on cash and match fund some of our ZDP's which mature in early 2016.

 

·; In April, we sold 22.8% of our TAL International Group position in a successful secondary share offering to create a gain of $10.8 million.

 

·; On 6 May 2011, the JZCP Board of Directors recommended a final dividend of 7.5 cents per share, and declared a special dividend of 2.0 cents per share, payable on 1 July 2011.

 

 

 

  

European Strategy

 

Our European portfolio has continued to perform well during the first quarter of the financial year with our existing assets in Spain showing strong growth and we are very well positioned to take advantage of an attractive investment pipeline.

The European Micro cap Fund (of which we own 75%) made further acquisitions in the Spanish market during the period that complement our existing assets. The fund acquired Docout, a provider of digitalization, document processing and storage services to Spanish financial institutions, utilities and insurance companies on 7 April 2011 for €11.0 million. In addition, JZCP directly loaned Docout €2.0 million for working capital.

In addition, on 5 May 2011 the fund acquired Grupo Ombuds, a leading provider of security, surveillance and facility services to public sector and blue-chip clients in Spain for €12.7 million. JZCP also loaned €8.5 million directly to this entity. The Company's service offering includes: personal security protection to government officials and corporate executives; asset protection and security services to public and corporate buildings; and the provision of ancillary facility services. The Company is a niche player with strong growth potential and has a leading market share in Spain.

The other two micro cap companies that were purchased within the last twelve months were Factor Energia, a Spanish energy distribution business, and Xacom, a distribution channel for large telecom companies in Spain. They were purchased for a total investment of €21.1 million. All four investments represent 9.5% of the total assets as at 31 May 2011.

A broad range of potential investments exists for JZCP in Europe, particularly in Spain where there are a number of opportunities that fit well with the fund's value oriented investment approach. JZCP will continue to make opportunistic investments in Europe and aims, over time, to invest up to 20% of its portfolio in the region.

JZCP's European portfolio is aimed at providing shareholders with geographical diversification, enabling the Company to benefit from the ongoing recovery in Europe. The Company's European strategy benefits from the expertise of seven investment professionals and a support team that are based in London and Madrid.

The team, headed by Jock Green-Armytage and Miguel Rueda, has been investing successfully in Europe for over 12 years. It has built a comprehensive proprietary network across the Continent in line with JZCP's strategy of sourcing deals directly with high quality companies.

US Investments

Our US private investments continue to perform well. Due primarily to the positive performance of three of our investments; Galson Laboratories, Dantom Systems, Inc. and Dekko Tech Technologies, LLC, we have written up this portfolio by $0.16 per share. This increase was offset by a decrease in value in our publicly traded equities which have recently been hurt by uncertainty in US stock markets. However, the underlying businesses continue to perform positively.

 

 Portfolio

 

At 31 May 2011, the Company's investment assets consisted of 42 investments totaling $677.2 million:

 

($000's, except for number of investments)

Number of Investments as of 31/5/2011

28/2/2011

 

 31/5/2011

 

 

 

Variance - %

Micro Cap Portfolio

 13

$230,601

$253,056

9.7%

European Investments

4

32,899

64,378

95.7%

Mezzanine Investments

9

48,499

48,847

0.7%

Legacy Portfolio

7

42,620

37,996

(10.9%)

Total Private Investments

33

$354,619

$404,277

14.0%

Listed Equity

3

105,016

89,081

(15.2%)

Bank Debt

6

34,121

35,574

4.3%

Cash

172,267

140,021

(18.7%)

UK Gilts

0

8,247

Total Listed Investments (including cash)

9

$311,404

$272,923

(12.4%)

Total Investment Assets

42

$666,023

$677,200

1.7%

 

40.3% of the portfolio is invested in "liquid" assets, which consist of cash, UK gilts, listed equities, and listed debt. These asset classes are valued at third party quoted prices. The remaining portion of the portfolio is invested in private investments in US or European micro caps or mezzanine debt. These investments are valued at fair value by the directors of JZCP each quarter.

 

As a point of reference, the average purchase multiple of the US micro cap investments was 6.1x. The current average enterprise multiple used for these investments at 31 May 2011 was 7.0x, due to positive market conditions raising public multiples upon which our valuations are based. In addition, these micro cap businesses continue to be leveraged with debt senior to JZCP at just over 1.0x trailing twelve months EBITDA.

 

After the TAL secondary sale mentioned above, which accounted for 9.9% of the reduction in the listed equity values for the three months ended 31 May 2011, these listed investments decreased 5.3%, as equity markets in the US dipped due to concerns about a slower-than-anticipated economic recovery. Our listed bank debt, both first and second lien investments, increased slightly as continued bank recoveries increased across-the-board loan prices. Our mezzanine investments were essentially flat. The US micro cap portfolio increased 9.7% during the three month period due to the Nashville Chemical acquisition and an increase in the value of selected investments. Of the 22 mezzanine and micro cap investments in our portfolio, all but one are current on their interest payments as of 31 May 2011.

 

The top ten investments as of 31 May 2011 were as follows:

 

($000's)

Asset Category

Original Cost

Valuation as of 31/5/2011

% of Portfolio Valuation

as of 31/5/2011

European Investments

Micro cap

$64,132

$64,378

12.2%

 

Safety Insurance Group, Inc.

Listed Equity

6,816

51,955

9.8%

 

Accutest Holdings, Inc.

Micro cap

34,516

44,062

8.3%

 

Wound Care Solutions, LLC

Micro cap

38,858

42,014

7.9%

 

Dantom Systems, Inc.

Micro cap

20,947

38,198

7.2%

 

TAL International Group, Inc.

Listed Equity

10,652

35,915

6.8%

 

Continental Cement Company, LLC

Mezzanine

28,082

28,556

5.4%

 

BG Holdings, Inc.

Micro cap

21,832

26,257

5.0%

 

Dental Services Group, Inc.

Micro cap

27,604

24,227

4.6%

 

Healthcare Products Holdings, Inc.

Legacy

28,803

22,646

4.3%

 

Top Ten Investments

$282,242

$378,208

71.5%

 

Remaining Investments

155,280

150,724

28.5%

 

Total Portfolio

$437,522

$528,932

100.0%

 

 

The portfolio is diversified across the following business sectors:

 

Number of Companies

% of Portfolio Valuation

as of 31/5/2011

Health Care Equipment & Services

6

23.5%

Support Services

11

23.4%

House, Leisure & Personal Goods

5

2.8%

Financial General

8

23.2%

Industrial Engineering

5

11.9%

Construction Materials

4

5.8%

Other

3

9.4%

Total Portfolio

42

100.0%

 

Balance Sheet

 

Below is a summary of JZCP's balance sheet as of the relevant dates:

 

($000's)

 28/2/2011

 31/5/2011

Cash

$172,267

$140,021

UK Treasury Gilts

0

8,247

Listed Equities

105,016

89,081

Bank Debt

34,121

35,574

Private Investments

354,619

404,277

Other Assets (1)

464

468

Total Assets

$666,487

$677,668

 - Liabilities

(3,358)

(3,588)

 - Zero Dividend Preferred Shares

(82,341)

(84,816)

Net Asset Value

$580,788

$589,264

(1) Includes accrued dividends on Listed Equities.

 

 

For further information:

 

Neil Doyle/ Ed Berry +44 (0)20 7269 7237 /7297

Financial Dynamics

 

David Zalaznick +1 212 572 0800

Jordan/Zalaznick Advisers, Inc.

 

About JZCP

 

JZCP is a closed ended investment company listed on the London Stock Exchange which invests in high quality US and European micro cap companies. Our objective is to achieve a superior overall return comprised of a current yield and significant capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc ("JZAI") which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of micro cap companies to help build better businesses, create value and deliver strong returns to our investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities.

For more information please visit our website at www.jzcp.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPGUCGQUPGGQU
Date   Source Headline
22nd Apr 20243:03 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNProposed Investment in the Secondary Fund for the Purpose of Investing in Follow-on Flex Pack and Proposed Return of Capital and Notice of Extraordinary General Meeting
22nd Mar 20243:00 pmPRNNet Asset Value(s)
21st Feb 202411:55 amPRNNet Asset Value(s)
13th Feb 20249:43 amPRNHolding(s) in Company
22nd Jan 20244:44 pmPRNNet Asset Value(s)
21st Dec 20235:01 pmPRNNet Asset Value(s)
20th Dec 202311:20 amPRNDirector/PDMR Shareholding
18th Dec 20237:00 amPRNRepayment of Senior Facility
14th Dec 20237:00 amPRNUpdate in relation to Secondary Sale
22nd Nov 20235:20 pmPRNNet Asset Value(s)
9th Nov 20237:00 amPRNHalf-year Report
23rd Oct 20232:36 pmPRNNet Asset Value(s)
22nd Sep 20233:09 pmPRNNet Asset Value(s)
21st Aug 20233:00 pmPRNNet Asset Value(s)
25th Jul 20233:59 pmPRNResult of AGM
21st Jul 20233:00 pmPRNNet Asset Value(s)
27th Jun 202310:29 amPRNNotice of AGM
21st Jun 20234:30 pmPRNNet Asset Value(s)
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20226:26 pmPRNNet Asset Value(s)
23rd May 20227:00 amPRNFurther Update in relation to Secondary Sale
7th Apr 20227:00 amPRNUpdate: Secondary Sale and
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
23rd Mar 202210:35 amPRNNet Asset Value(s)
21st Mar 20227:00 amPRNJZCP European Micro Cap Investments
21st Feb 202210:28 amPRNNet Asset Value(s)
31st Jan 202211:06 amRNSSecond Price Monitoring Extn
31st Jan 202211:01 amRNSPrice Monitoring Extension
26th Jan 20226:07 pmPRNJZCP Agrees New Senior Facility
21st Jan 20229:34 amPRNNet Asset Value(s)
21st Dec 20219:25 amPRNNet Asset Value(s)
22nd Nov 20219:39 amPRNNet Asset Value(s)
11th Nov 20217:00 amPRNHalf-year Report
9th Nov 202110:00 amPRNNotice of Interim Results
1st Nov 20212:41 pmPRNDirector Declaration
21st Oct 20219:43 amPRNNet Asset Value(s)
7th Oct 20217:00 amPRNSenior Facility Amendments
6th Oct 20212:53 pmPRNDirector Declaration
24th Sep 20219:39 amPRNNet Asset Value(s)
23rd Aug 20219:01 amPRNNet Asset Value(s)
12th Aug 20214:41 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20212:06 pmRNSSecond Price Monitoring Extn
12th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 202111:23 amPRNIssue of Loan Notes & Shares, Redemption of Loan Stock
21st Jul 20219:51 amPRNNet Asset Value(s)
6th Jul 20212:20 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.